MedTrace Logo

Efficacy and Safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean Patients With Cold Hypersensitivity in the Hands

NCT02645916 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2017-11-29

No results posted yet for this study

Summary

The Purpose of this trial is to investigate the efficacy and safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang(DSGOST) on Korean Patients With Cold Hypersensitivity in the Hands

Conditions

  • Cold Hypersensitivity

Interventions

DRUG

Danggui-Sayuk-Ga-Osuyu-Saenggang-tang

Usage: 3g, three times a day, each taken before or between meals Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

DRUG

Placebo: corn starch

Usage: 3g three times a day, each taken before or between meals Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

Sponsors & Collaborators

  • Sangji University Oriental Medical Hospital

    collaborator UNKNOWN

  • Semyung University Affiliated Oriental Medical Hospital

    collaborator OTHER

  • Kyunghee University Medical Center

    collaborator OTHER

  • Kyung Hee University Hospital at Gangdong

    collaborator OTHER

  • DongGuk University

    collaborator OTHER

  • Gachon University Gil Oriental Medical Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
59 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2017-08-01
Completion
2017-08-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02645916 on ClinicalTrials.gov